SCHEMBL19628263

SCHEMBL19628263

C=CCNC1=C(NCC)C(=O)c2ccccc2C1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.67
L3MBTL1 Q9Y468 6/20 0.67
LMNA P02545 4/20 0.67
KMT2A Q03164 4/20 0.67
MITF O75030 3/20 0.67
HTT P42858 3/20 0.67
CASP3 P42574 3/20 0.67
NSD2 O96028 3/20 0.67
SENP8 Q96LD8 2/20 0.67
SENP7 Q9BQF6 2/20 0.67
SENP6 Q9GZR1 2/20 0.67
MAPT P10636 10/20 0.58
TDP1 Q9NUW8 3/20 0.58
USP2 O75604 1/20 0.58
POLB P06746 1/20 0.58
APAF1 O14727 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TSHR P16473 1/20 0.40
MAOA P21397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16297128 0.91 LMNA (0.77) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL7952246 0.83 ALDH1A1 (0.58) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16297131 0.82 ALDH1A1 (0.57) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16297214 0.82 KMT2A (0.65) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16296919 0.80 LMNA (1.00) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16297003 0.80 MAPT (0.68) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16296768 0.76 HSP90AA1 (0.57) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL19625609 0.76 LMNA (0.53) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL1823503 0.75 ALDH1A1 (0.60) ALDH1A1L3MBTL1LMNAKMT2AMITF
SCHEMBL16296834 0.74 APAF1 (0.61) ALDH1A1L3MBTL1LMNAKMT2AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334842-A1 INHIBITORS OF THE MITF MOLECULAR PATHWAY UNIVERSITY OF KANSAS 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334842-A1 INHIBITORS OF THE MITF MOLECULAR PATHWAY MITF, TFEB, TYR ALDH1A1 2444/4885L3MBTL1 2985/4885LMNA 3726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.